Share Price | Butterfly Network, Inc. Stock Analysis & Recommendation

Q: What does Butterfly Network, Inc. do?

Overview:Butterfly Network, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot:Most recent Net Sales: 21 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -14 Million (Quarterly Results - Mar 2025) Market-cap: USD 544.04 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.64 Return on Equity: -25.22% Price to Book: 2.27 Contact Details:Registrar Address: Not available.

Q: Is Butterfly Network, Inc. overvalued or undervalued?

As of 29 March 2021, the valuation grade for Butterfly Network, Inc. moved from does not qualify to risky, indicating a deterioration in its financial standing. The company appears to be overvalued, given its negative P/E ratio and poor return metrics. Key valuation ratios include a Price to Book Value of 2.56, an EV to EBIT of -6.89, and an EV to Sales of 5.38, all of which suggest significant challenges in generating profits relative to its valuation.In comparison with peers, Butterfly Network's EV to EBITDA of -4.6501 is notably worse than Standard BioTools, Inc. at -3.0601, highlighting its relative underperformance. Additionally, while the stock has shown a strong 1-week return of 21.94% compared to the S&P 500's 1.05%, its year-to-date return of -39.42% starkly contrasts with the S&P 500's 12.22%, reinforcing the notion that the stock is struggling in the long term.

Q: Is Butterfly Network, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Butterfly Network, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD and Bollinger Bands are bullish, while the daily moving averages are mildly bearish. The KST shows a bullish signal on the weekly but is mildly bearish on the monthly. Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 19.09% and 12.45% respectively, but it has significantly underperformed over the year-to-date and longer time frames.

Results Declared: Butterfly Network, Inc. has declared results on 30 Apr 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.55 M

Shareholding (Mar 2026)

FII

9.69%

Held by 80 FIIs

DII

62.96%

Held by 38 DIIs

Promoter

4.70%

How big is Butterfly Network, Inc.?

22-Jun-2025

As of Jun 18, Butterfly Network, Inc. has a market capitalization of 544.04 million and reported net sales of 85.63 million, with a net profit loss of 64.70 million. Shareholder's funds are 168.83 million, and total assets amount to 256.08 million.

View full answer

What does Butterfly Network, Inc. do?

22-Jun-2025

Butterfly Network, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $21 million and a net loss of $14 million as of March 2025. It has a market cap of $544.04 million and does not pay dividends.

View full answer

Is Butterfly Network, Inc. overvalued or undervalued?

20-Sep-2025

As of March 29, 2021, Butterfly Network, Inc. is considered a risky investment due to its overvaluation, negative P/E ratio, poor return metrics, and significant underperformance compared to peers and the S&P 500.

View full answer

Is Butterfly Network, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Butterfly Network, Inc. has a neutral technical trend with mixed indicators, showing bullish signals on the weekly MACD and Bollinger Bands but mildly bearish daily moving averages, while the stock has outperformed the S&P 500 recently but underperformed year-to-date.

View full answer

Compare Butterfly Network, Inc. with Similar Stocks

908 Devices, Inc.Axogen, Inc.Standard BioTools, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

The company has declared negative results in Mar'2025 after 3 consecutive positive quarters

INTEREST(9M) At USD 1.05 MM has Grown at 72.25%

Risky - Negative EBITDA

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 996 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.69

Return on Equity

-36.61%

Price to Book

4.88

Revenue and Profits:

Net Sales:

27 Million

(Quarterly Results - Mar 2026)

Net Profit:

-13 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

25.44%

6 Months

90.13%

1 Year

94.5%

2 Years

319.8%

3 Years

97.21%

4 Years

41.81%

5 Years

-65.1%

Butterfly Network, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

19.36%

EBIT Growth (5y)

9.95%

EBIT to Interest (avg)

-132.04

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.64

Sales to Capital Employed (avg)

0.36

Tax Ratio

0.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

65.49%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.88

EV to EBIT

-10.52

EV to EBITDA

-11.81

EV to Capital Employed

13.73

EV to Sales

9.66

PEG Ratio

Dividend Yield

ROCE (Latest)

-130.42%

ROE (Latest)

-36.61%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 40 Schemes (22.65%)

Foreign Institutions

Held by 80 Foreign Institutions (9.69%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -15.87% vs 46.51% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 16.99% vs 55.00% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.50",
          "val2": "31.50",
          "chgp": "-15.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.70",
          "val2": "-9.60",
          "chgp": "-21.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.40",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-4.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-12.70",
          "val2": "-15.30",
          "chgp": "16.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-508.40%",
          "val2": "-361.30%",
          "chgp": "-14.71%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 18.88% vs 24.58% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -6.34% vs 45.77% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "97.60",
          "val2": "82.10",
          "chgp": "18.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-67.60",
          "val2": "-60.00",
          "chgp": "-12.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "1.30",
          "chgp": "15.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.50",
          "val2": "-5.90",
          "chgp": "-44.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-77.10",
          "val2": "-72.50",
          "chgp": "-6.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-774.90%",
          "val2": "-857.30%",
          "chgp": "8.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

26.50

31.50

-15.87%

Operating Profit (PBDIT) excl Other Income

-11.70

-9.60

-21.87%

Interest

0.30

0.40

-25.00%

Exceptional Items

0.00

-4.70

100.00%

Consolidate Net Profit

-12.70

-15.30

16.99%

Operating Profit Margin (Excl OI)

-508.40%

-361.30%

-14.71%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -15.87% vs 46.51% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 16.99% vs 55.00% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

97.60

82.10

18.88%

Operating Profit (PBDIT) excl Other Income

-67.60

-60.00

-12.67%

Interest

1.50

1.30

15.38%

Exceptional Items

-8.50

-5.90

-44.07%

Consolidate Net Profit

-77.10

-72.50

-6.34%

Operating Profit Margin (Excl OI)

-774.90%

-857.30%

8.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 18.88% vs 24.58% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -6.34% vs 45.77% in Dec 2024

All Annual Results

Company CV

About Butterfly Network, Inc.

Butterfly Network, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available